Benzinga | Dec 23, 2020 09:13AM EST

Outlook Therapeutics FY20 EPS $(0.67) Up From $(1.98) YoY

Outlook Therapeutics (NASDAQ:OTLK) reported quarterly losses of $(0.67) per share. This is a 66.16 percent increase over losses of $(1.98) per share from the same period last year.